Verastem
Hiring for 8 positions
Verastem Oncology is committed to advancing cancer treatment for patients with RAS/MAPK pathway mutations, a significant driver of tumor growth and resistance. Their innovative therapies, like the FDA-approved AVMAPKI FAKZYNJA CO-PACK, specifically target recurrent KRAS-mutated low-grade serous ovarian cancer, addressing a critical unmet need in oncology. With ongoing clinical trials and an expanding pipeline, Verastem is poised to make a substantial impact in the evolving landscape of cancer care.
No jobs found. Subscribe below to get notified when we find something for you.
Searching